Concepedia

Arthur Dyer

AD

6

Publications

246

Citations

6

H-Index

2016

Active since

Affiliations

University of Oxford(Current)

PsiOxus Therapeutics (United Kingdom)

Arthur Dyer is an author at University of Oxford specializing in cancer research, medicine, and oncology.

ORCID

Top concepts

Publications per year

2016–2021

6

Publications

6

Bi- and tri-valent T cell engagers deplete tumour-associated macrophages in cancer patient samples

Eleanor M. Scott, Egon J. Jacobus, Brian Lyons et al. · Journal for ImmunoTherapy of Cancer · 2019 · 72 citations · Full text

Oncolytic herpesvirus expressing PD-L1 BiTE for cancer therapy: exploiting tumor immune suppression as an opportunity for targeted immunotherapy

Hena Khalique, Richard Baugh, Arthur Dyer et al. · Journal for ImmunoTherapy of Cancer · 2021 · 54 citations · Full text

Oncolytic Group B Adenovirus Enadenotucirev Mediates Non-apoptotic Cell Death with Membrane Disruption and Release of Inflammatory Mediators

Arthur Dyer, Ying Di, Hugo Calderón et al. · Molecular Therapy — Oncolytics · 2016 · 52 citations · Full text

Antagonism of Glycolysis and Reductive Carboxylation of Glutamine Potentiates Activity of Oncolytic Adenoviruses in Cancer Cells

Arthur Dyer, Benjamin Schoeps, Sally Frost et al. · Cancer Research · 2018 · 35 citations

Group B adenovirus enadenotucirev infects polarised colorectal cancer cells efficiently from the basolateral surface expected to be encountered during intravenous delivery to treat disseminated cancer

Suet Lin Chia, Janet Lei-Rossmann, David Ferguson et al. · Virology · 2017 · 17 citations

, , +8

Rows per page

1–5 of 6